SGRYSurgery Partners, Inc.

$14.04

Price

$14.04-40%1Y
1M-7.8%1Y-40%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value71
Quality72
Momentum44
Growth44
Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States ("U.S."), with more than 200 locations in 30 states, including ambulatory surgery centers ("ASCs"), short-stay surgical hospitals ("surgical hospitals"), and multi-specialty physician practices, among others.

In the company’s own words · 10-K filed Mar 2, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$1.90B
1Y Return-40%
5Y Return-74%

Business segments

Q1 2026 · $810.9M

The company’s own SEC segment disclosure.

  • Private Insurance$398.9M49%
  • Government$357.4M44%
  • Self Pay$19.2M2%
  • Other Services$18.8M2%
  • Other Patient Service Revenue Sources$16.6M2%

Surgery Partners, Inc. (SGRY) reported revenue of $849M in Q2 2026 (quarter ended June 30, 2026), up 2.7% from the same quarter a year earlier. That came with net loss of $15M. For the full year FY2025, revenue was $3.31B (+6.2% year on year) and net income −$78M. Its largest product in 2026-Q1 was Private Insurance at $399M, 49% of the disclosed total, just ahead of Government at 44%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.